How many insider trades does FilingIQ track for EYES?

FilingIQ tracks 297 Form 4 insider transactions for EYES (SECOND SIGHT MEDICAL PRODUCTS INC), covering filings from Jan 5, 2015 onwards. 0 of those are dated within the last 90 days.

Are EYES insiders net buyers or net sellers?

Across the full Form 4 history for EYES, 93 transactions (31%) were open-market purchases and 41 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does EYES insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

EYES insider trading

Cboe US

SECOND SIGHT MEDICAL PRODUCTS INC: insider trade history from SEC Form 4 filings.

Total Form 4 trades

297

Last 90 days

Buys / sells

31% / 14%

Market cap

—

About SECOND SIGHT MEDICAL PRODUCTS INC

The fund is an exchange-traded fund ("ETF") that seeks to meet its objective by having Corgi Strategies, LLC (the "adviser") actively manage the fund and, under ordinary market conditions, invest at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of companies materially involved in the development and deployment of technologies that collect, process, secure, analyze, and operationalize data for monitoring, risk management, security, compliance, and operational visibility across public and private environments. It is non-diversified.

EYES insider activity at a glance

FilingIQ tracks 297 insider transactions for EYES in filings since Jan 5, 2015. The most recent transaction is dated Jun 14, 2022.

Across the full history, 93 open-market purchases and 41 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on EYES insider trades is 58.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live EYES trades on FilingIQ Raw filings on SEC EDGAR

Latest EYES Form 4 filings

Larson Alexandra L.P.

A Jun 10, 2021

McGuire Jonathan Will

D May 19, 2020

RYAN WILLIAM PATRICK Chief Operating Officer

ADM Feb 21, 2020

McGuire Jonathan Will Chief Executive Officer

SAM Feb 21, 2020

Blake John T Chief Financial Officer

ADM Feb 21, 2020

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for EYES?: FilingIQ tracks 297 Form 4 insider transactions for EYES (SECOND SIGHT MEDICAL PRODUCTS INC), covering filings from Jan 5, 2015 onwards. 0 of those are dated within the last 90 days.
Are EYES insiders net buyers or net sellers?: Across the full Form 4 history for EYES, 93 transactions (31%) were open-market purchases and 41 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does EYES insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

Methodology & sources

Every EYES insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.